Antimicrobial Susceptibility of Ertapenem in Neisseria gonorrhoeae Isolates Collected Within the China Gonococcal Resistance Surveillance Programme (China-GRSP) 2018
Wen-Qi Xu,Xiao-li Zheng,Jing-Wei Liu,Qian Zhou,Xiao-Yu Zhu,Jin Zhang,Yan Han,Kai Chen,Shao-Chun Chen,Xiang-Sheng Chen,Yue-Ping Yin,Xiao-Li Zheng
DOI: https://doi.org/10.2147/IDR.S335252
2021-10-11
Infection and Drug Resistance
Abstract:Wen-Qi Xu, 1, 2 Xiao-li Zheng, 1, 2 Jing-Wei Liu, 1, 2 Qian Zhou, 1, 2 Xiao-Yu Zhu, 1, 2 Jin Zhang, 1, 2 Yan Han, 1, 2 Kai Chen, 1, 2 Shao-Chun Chen, 1, 2 Xiang-Sheng Chen, 1, 2 Yue-Ping Yin 1, 2 1 STD Reference Laboratory, Institute of Dermatology and Hospital for Skin Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, People's Republic of China; 2 STD Reference Laboratory, National Center for Sexually Transmitted Diseases Control, Chinese Center for Disease Control and Prevention, Nanjing, People's Republic of China Correspondence: Yue-Ping Yin STD Reference Laboratory, Institute of Dermatology and Hospital for Skin Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, People's Republic of China Tel/Fax +86 258 547 8024 Email Purpose: This study aimed to determine the minimum inhibitory concentrations (MICs) of ertapenem on Neisseria gonorrhoeae collected from eight Chinese provinces in 2018. Methods: The MICs of ertapenem on 503 Neisseria gonorrhoeae isolates (415 isolates selected randomly and 88 isolates selected with preference) were measured using the agar dilution method. For comparison, the MICs of ceftriaxone and azithromycin were detected. Results: Among 415 randomly selected isolates, the MIC range for ertapenem was from ≤ 0.008 mg/L to 0.5 mg/L. The corresponding MIC 50 and MIC 90 were 0.06 and 0.125 mg/L, respectively. Twelve of 415 isolates (2.9%) exhibited MIC values ≥ 0.25 mg/L, and only one isolate (0.2%) had a MIC of 0.5 mg/L. By comparing all 503 tested isolates, a correlation of r = 0.487 ( P < 0.001) between ertapenem and ceftriaxone MIC was observed, and the correlation between MICs of ertapenem and azithromycin was low ( r = − 0.12, P = 0.007). In 24 ceftriaxone-decreased susceptibility isolates, four isolates (16.7%) showed a MIC ≥ 0.25 mg/L for ertapenem. In 85 azithromycin resistant isolates, three isolates (3.5%) showed a MIC ≥ 0.25 mg/L for ertapenem. Conclusion: The in vitro results suggest that ertapenem has satisfactory susceptibility in isolates collected from eight provinces in China; hence, it might be a promising treatment option for resistant gonococcal infections. Keywords: Neisseria gonorrhoeae , treatment, ertapenem, antimicrobial resistance Gonorrhea, caused by Neisseria gonorrhoeae , is one of the commonly seen sexually transmitted diseases with a total global incidence of approximately 86.9 million per year. 1 N. gonorrhoeae can cause urogenital infection and extragenital infection. It usually leads to dysuria and urethral discharge in men and frequently causes asymptomatic genital tract infection in women. If left untreated, it may lead to severe sequelae such as pelvic inflammatory disease and infertility. 2 Moreover, it can even facilitate the risk of HIV acquisition and transmission. 3 To prevent complications and control the transmission, successful treatment is of great significance. Ceftriaxone and azithromycin in various doses are recommended as first-line treatments in guidelines in America, 4 Australia, 5 Canada, 6 Europe, 7 New Zealand, 8 and by the World Health Organization (WHO). 9 Monotherapy with ceftriaxone (1 g intramuscularly in a single dose) for uncomplicated gonococcal infections is recommended as the first-line treatment according to the current guidelines in China. 10 However, N. gonorrhoeae has developed resistance to all previously used antimicrobial therapies and shows decreased susceptibility to ceftriaxone (DSC, defined as isolates with ceftriaxone MIC ≥0.25 mg/L in China currently) which poses a significant global healthcare burden. 11–13 The emergence of N. gonorrhoeae isolates with a multidrug resistant or extremely drug-resistant profile highlights the importance of considering alternate therapy. Noteworthy, one treatment failure with 1 g ceftriaxone was reported in UK, but that infection was cleared with intravenous ertapenem 1 g once daily for 3 days. 14 Ertapenem belongs to the class of carbapenem antibiotics, which interacts with penicillin binding proteins (PBPs) located on the bacterial cell wall. In particular, its inhibitory effect to PBPs 2 and 3 disturbs the final transpeptidation step in the synthesis of peptidoglycan, an essential component of the bacterial cell wall. Subsequently, d -Abstract Truncated-
pharmacology & pharmacy,infectious diseases